Viewing Study NCT05217693


Ignite Creation Date: 2025-12-25 @ 1:03 AM
Ignite Modification Date: 2025-12-25 @ 11:16 PM
Study NCT ID: NCT05217693
Status: RECRUITING
Last Update Posted: 2025-07-24
First Post: 2021-12-29
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A First-in-human of Multiplle Doses of BB-1705 in Subjects With Locally Advanced/Metastatic Solid Tumors
Sponsor: Bliss Biopharmaceutical (Hangzhou) Co., Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module